For striae alba, the available comparison indicates similar overall clinical efficacy, but a major difference in treatment efficiency: both a 1565-nm non-ablative fractional Erbium:glass laser and a dual-wavelength fractional picosecond Nd:YAG laser produce approximately 48% overall improvement and 31% improvement in skin texture. Atrophy improvement is approximately 30% with the 1565-nm laser versus 35% with the picosecond system, while the picosecond protocol requires roughly one-quarter of the treatment time.
The principal distinction is operational rather than a dramatic difference in overall effectiveness: the picosecond 1064/532-nm system may provide a modest advantage in atrophy correction and substantially shorter treatment times, while the 1565-nm Erbium:glass laser uses a single-pass dermal thermal protocol with established non-ablative fractional behavior.
What the Clinical Comparison Shows
Overall improvement is broadly comparable
Both technologies improve the visible appearance of mature white stretch marks through remodeling of damaged dermal tissue. The reported overall improvement is approximately 48% for each device category.
This similarity means that wavelength and pulse duration alone should not be interpreted as determining a clearly superior clinical result. Treatment response also depends on lesion age, width, location, skin phototype, treatment spacing, energy delivery, and the number of sessions.
Texture improvement is also similar
The two approaches produce approximately 31% improvement in skin texture. This reflects remodeling of the irregular, atrophic surface rather than complete restoration of normal skin.
Both systems are therefore better understood as methods for reducing the contrast and depth of striae alba, not as treatments that reliably erase the lesions.
Picosecond treatment may improve atrophy somewhat more
The reported improvement in atrophy is approximately 30% with the 1565-nm Erbium:glass laser and 35% with the fractional picosecond Nd:YAG protocol.
The difference is relatively modest, so it should not be treated as proof that picosecond treatment is universally superior. It does suggest that the picosecond protocol may have a practical or perceptual advantage when lesion depth and dermal depression are the primary concerns.
How the Operating Parameters Differ
1565-nm Erbium:glass protocol
The reported 1565-nm protocol uses:
- A 12-mm square spot size
- Approximately 400 mJ/cm² spot density, as reported in the reference
- 0.5-2.0 Hz frequency
- 40 J fluence
- One treatment pass
The device creates fractional microscopic thermal treatment zones in the dermis while preserving the epidermal barrier. Its intended effect is controlled heating that stimulates fibroblast activity, collagen remodeling, and reorganization of the extracellular matrix.
The parameter terminology should be verified against the specific device manufacturer’s protocol. “Spot density,” pulse energy, and fluence are not interchangeable measurements, and the reported combination of 400 mJ/cm² and 40 J cannot be compared directly with picosecond microbeam energy without knowing the treatment area and device-specific definitions.
Fractional picosecond Nd:YAG protocol
The picosecond approach uses a fractionated handpiece with:
- A 6-mm spot size
- Sequential treatment at 1064 nm, using approximately 1.3 mJ per microbeam
- 10 Hz repetition rate
- Four passes at 1064 nm
- Immediate treatment at 532 nm, using approximately 0.4 mJ per microbeam
- Two passes at 532 nm
This is a multi-pass, dual-wavelength protocol rather than a single-pass thermal exposure. The 1064-nm wavelength is used first, followed by 532 nm, allowing the operator to combine the treatment characteristics of both wavelengths within the same session.
The measurements are not directly equivalent
The Erbium:glass settings are expressed using terms such as fluence, frequency, and spot density, whereas the picosecond settings emphasize microbeam energy, wavelength, repetition rate, and number of passes.
Consequently, the numerical values cannot be ranked by simply comparing “40 J” with “1.3 mJ.” They describe different energy-delivery systems, beam structures, pulse durations, and treatment geometries.
Why the Technologies Can Produce Similar Results
Both stimulate dermal remodeling
Striae alba are mature, hypopigmented, atrophic scars involving altered collagen and elastin architecture. Neither device restores the original tissue instantly; both aim to stimulate remodeling that reduces the depth and irregularity of the lesions.
The 1565-nm laser achieves this primarily through fractional dermal heating and microthermal treatment zones. The picosecond system uses very short pulses delivered through a fractional handpiece to promote remodeling in the papillary and superficial dermal tissue.
Non-ablative treatment preserves the surface barrier
The 1565-nm system is non-ablative: it coagulates selected dermal zones without vaporizing the epidermis. This generally supports faster re-epithelialization, less open-wound risk, and less downtime than fractional ablative CO2 or 2940-nm Er:YAG treatment.
The fractional picosecond protocol is likewise intended to remodel tissue without the broad epidermal vaporization associated with ablative lasers. Its clinical recovery profile should still be assessed from the actual device and settings rather than inferred solely from the word “picosecond.”
Dual wavelengths may broaden treatment behavior
The picosecond protocol combines 1064 nm and 532 nm in sequence. The treatment rationale is not simply that two wavelengths are automatically better, but that they provide different optical interactions and allow the operator to address the lesion with a combined protocol.
The reported advantage is therefore best framed as a potential improvement in treatment efficiency and atrophy response, not as evidence of universally superior collagen remodeling.
Understanding the Trade-offs
Treatment time favors picosecond technology
The most substantial operational difference is duration. The picosecond treatment requires approximately one-quarter of the time needed for the 1565-nm protocol in the reported comparison.
This can matter significantly in clinical practice, particularly for large treatment areas, high-volume practices, and patients who find prolonged procedures uncomfortable or inconvenient.
The 1565-nm protocol is operationally simpler
The reported Erbium:glass treatment uses a single pass at one wavelength. That may simplify procedural standardization and reduce the number of sequencing decisions during treatment.
By contrast, the picosecond protocol requires sequential passes at two wavelengths, with different microbeam energies and pass counts. It may therefore demand more deliberate technique, treatment mapping, and operator familiarity.
Device settings should not be transferred between platforms
A common error is to treat numerical parameters from one laser platform as if they were interchangeable with those from another. Pulse duration, beam profile, fractional coverage, microbeam distribution, spot size, and energy calibration all influence tissue exposure.
Protocols should therefore be selected and adjusted according to the specific device, handpiece, skin type, lesion characteristics, and clinical endpoint rather than copied solely from a published parameter set.
More efficacy does not mean complete correction
The reported atrophy difference, approximately 35% versus 30%, is clinically relevant but limited. Patients should expect partial improvement in depth, texture, and visibility rather than elimination of striae alba.
Treatment response can also vary substantially between body sites and between individual lesions. A numerical average should not be presented as a guaranteed result for an individual patient.
Non-ablative does not mean risk-free
Although both approaches generally have less downtime than ablative fractional lasers, they can still cause erythema, edema, discomfort, transient pigmentary alteration, or uneven response.
Skin phototype, recent tanning, treatment intensity, and post-treatment photoprotection remain important when managing the risk of post-inflammatory hyperpigmentation or prolonged irritation.
Making the Right Choice for Your Goal
The choice should be based on the clinical priority, treatment area, available device, operator experience, and the patient’s tolerance for procedure time and recovery.
- If your primary focus is overall visual improvement: Either technology is a reasonable option because reported overall improvement is approximately 48% for both.
- If your primary focus is skin texture: Both systems have comparable reported texture improvement of approximately 31%, so protocol quality and adequate treatment planning may matter more than wavelength selection alone.
- If your primary focus is reducing atrophy: The picosecond protocol has a modest reported advantage, with approximately 35% improvement compared with about 30% for the 1565-nm laser.
- If your primary focus is minimizing treatment time: The dual-wavelength picosecond system is favored because the reported treatment duration is approximately one-quarter that of the 1565-nm protocol.
- If your primary focus is procedural simplicity: The single-pass 1565-nm Erbium:glass protocol is operationally more straightforward than sequential 1064/532-nm picosecond treatment.
- If your primary focus is minimizing downtime: Both are non-ablative fractional approaches and generally offer faster recovery than ablative fractional lasers, although actual downtime depends on treatment intensity and patient factors.
For striae alba, the most defensible conclusion is that picosecond fractional Nd:YAG treatment offers greater time efficiency and a modest atrophy advantage, while 1565-nm Erbium:glass treatment delivers broadly comparable overall and texture outcomes through a simpler single-pass thermal protocol.
Summary Table:
| Parameter | 1565-nm Erbium:glass | Picosecond Nd:YAG |
|---|---|---|
| Overall improvement | ~48% | ~48% |
| Texture improvement | ~31% | ~31% |
| Atrophy improvement | ~30% | ~35% |
| Treatment time | Longer | ~1/4 of time |
| Wavelengths | 1565 nm | 1064 nm & 532 nm |
| Passes | Single pass | Six passes (4 at 1064nm, 2 at 532nm) |
| Mechanism | Non-ablative thermal | Fractional photomechanical |
Discover the ideal laser for your clinic. BELIS offers professional-grade systems like Erbium:glass and Picosecond Nd:YAG, tailored for aesthetic practices. Our experts can guide you to the best solution for striae alba and beyond. Contact us today to elevate your treatment offerings!
Related Products
- 9D 7D HIFU Vaginal RF Lifting Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
- Clinic Use IPL SHR ND YAG Laser Hair Removal RF Skin Tightening Machine
- Clinic Use IPL and SHR Hair Removal Machine with Nd Yag Laser Tattoo Removal
People Also Ask
- How do Ultherapy and Hifu treatments stimulate skin renewal? Unlock the Science of Non-Invasive Lifting
- Is a HIFU treatment painful? Discover Comfort Levels and Results for Non-Surgical Lifting
- Is HIFU treatment considered safe and what are the potential risks? A Guide to Safe Non-Invasive Skin Tightening
- How does HIFU treatment differ from other skin tightening procedures? Compare Non-Invasive Lifting vs. Surgery
- What are the primary benefits of HIFU treatment? Reveal a Youthful V-Line and Firm Skin Non-Invasively
